# MEDX holdings: all 31 positions

> All 31 MEDX holdings with weights, as of Jun 30, 2026. The top 3 are LLY 18.46%, ABBV 8.85% and NVS 6.89%. Download the full list as a CSV.

Data as of Jun 30, 2026. Rebuilt every trading night.

MEDX held 31 positions as of Jun 30, 2026. Eli Lilly & Co is the largest at 18.46%; the top 10 are 67.1% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/1683471/000119312526367636/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 18.46% |
| 2 | AbbVie Inc | ABBV | 8.85% |
| 3 | Novartis AG | NVS | 6.89% |
| 4 | Johnson & Johnson | JNJ | 5.59% |
| 5 | Alkermes PLC | ALKS | 5.53% |
| 6 | AstraZeneca PLC | AZN | 4.99% |
| 7 | Ionis Pharmaceuticals Inc | IONS | 4.53% |
| 8 | Bristol-Myers Squibb Co | BMY | 4.42% |
| 9 | Merck & Co Inc | MRK | 3.96% |
| 10 | Amgen Inc | AMGN | 3.91% |
| 11 | Alnylam Pharmaceuticals Inc | ALNY | 3.42% |
| 12 | Biogen Inc | BIIB | 3.09% |
| 13 | Pfizer Inc | PFE | 2.86% |
| 14 | GSK PLC | GSK | 2.71% |
| 15 | CRISPR Therapeutics AG | CRSP | 2.64% |
| 16 | Regeneron Pharmaceuticals Inc | REGN | 2.06% |
| 17 | Beam Therapeutics Inc | BEAM | 1.51% |
| 18 | Galectin Therapeutics Inc | GALT | 1.14% |
| 19 | Intellia Therapeutics Inc | NTLA | 1.12% |
| 20 | Sandoz Group AG | SDZNY | 0.80% |
| 21 | Replimune Group Inc | REPL | 0.73% |
| 22 | Vanda Pharmaceuticals Inc | VNDA | 0.73% |
| 23 | Haleon PLC | HLN | 0.60% |
| 24 | Lantern Pharma Inc | LTRN | 0.55% |
| 25 | Editas Medicine Inc | EDIT | 0.47% |
| | Cash and other net assets | | 7.36% |

The largest 25 of 31 positions are shown. All of them: https://etfiq.com/funds/medx/holdings/medx-holdings.csv (CSV) or https://etfiq.com/data/books/medx.json (JSON).

Fund page: https://etfiq.com/funds/medx

Cite: ETFIQ, Holdings of MEDX, data as of Jun 30, 2026. https://etfiq.com/funds/medx/holdings/